BREAKING: Breakout Ventures has just announced the closing of its latest fund, totaling an impressive $114 million, to capitalize on groundbreaking advancements in AI biology and scientific research. This urgent investment comes on the heels of the successful acquisition of Surf Bio by Halozyme Therapeutics for up to $400 million, highlighting the lucrative potential of startups in this rapidly evolving field.
The San Francisco-based venture firm, known for its focus on early-stage technology companies, is gearing up to support innovations in biology, chemistry, and artificial intelligence. Fund III has garnered backing from prominent investors including Cortes Capital, S-Cubed Capital, and The Kraft Group, alongside new entrants like JIMCO and Korea Omega Investment Corporation.
In a significant move reflecting its commitment to nurturing talent, Breakout Ventures has promoted Nima Ronaghi to partner. Managing Partner Lindy Fishburne emphasized the transformative potential of this fund, stating, “As AI is unleashed on the scale of data in biology and chemistry, we are experiencing incredible speed, momentum, and efficiency that are fundamentally changing cost curves and return profiles.”
The new fund will build on Breakout’s history of transforming scientific breakthroughs into commercial products. The firm previously launched its second fund in 2021, and with this latest financial boost, it aims to continue investing in startups like Cytovale, which has developed an AI-enabled diagnostic test for sepsis, and Twelve, which produces aviation fuel from captured carbon.
With immediate plans already in motion, Breakout Ventures has begun deploying capital from Fund III. Initial investments include Reach Industries, which is developing innovative computer vision systems for regulated industries. The firm is also backing two stealth-mode startups that focus on enhancing the commercialization of scientific discoveries and creating computational tools for small-molecule discovery.
This surge in funding represents a critical moment for the scientific startup landscape, as investors increasingly recognize the potential of AI to drive significant advancements in healthcare and environmental sustainability. As these technologies develop, they promise to reshape industries and improve lives on a global scale.
Stay tuned for more updates as Breakout Ventures and its portfolio companies work to push the boundaries of science and technology, paving the way for the future of innovation.
